chr16-56872737-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_001126108.2(SLC12A3):c.1046C>T(p.Pro349Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000514 in 1,614,136 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P349A) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001126108.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC12A3 | NM_001126108.2 | c.1046C>T | p.Pro349Leu | missense_variant | 8/26 | ENST00000563236.6 | |
SLC12A3 | NM_000339.3 | c.1046C>T | p.Pro349Leu | missense_variant | 8/26 | ||
SLC12A3 | NM_001126107.2 | c.1043C>T | p.Pro348Leu | missense_variant | 8/26 | ||
SLC12A3 | NM_001410896.1 | c.1043C>T | p.Pro348Leu | missense_variant | 8/26 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC12A3 | ENST00000563236.6 | c.1046C>T | p.Pro349Leu | missense_variant | 8/26 | 1 | NM_001126108.2 | A1 | |
SLC12A3 | ENST00000438926.6 | c.1046C>T | p.Pro349Leu | missense_variant | 8/26 | 1 | A1 | ||
SLC12A3 | ENST00000566786.5 | c.1043C>T | p.Pro348Leu | missense_variant | 8/26 | 1 | P4 | ||
SLC12A3 | ENST00000262502.5 | c.1043C>T | p.Pro348Leu | missense_variant | 8/26 | 5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251466Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135912
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461878Hom.: 0 Cov.: 32 AF XY: 0.0000481 AC XY: 35AN XY: 727240
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74390
ClinVar
Submissions by phenotype
Familial hypokalemia-hypomagnesemia Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1996 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 06, 2022 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 18, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 349 of the SLC12A3 protein (p.Pro349Leu). This variant is present in population databases (rs121909383, gnomAD 0.007%). This missense change has been observed in individuals with Gitelman's syndrome (PMID: 8528245, 8900229, 21415153). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8592). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC12A3 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at